| Table 1. Embryo and CET cycle characteristics. | ||||
| Patients Characteristic | Description | Cyclogest group N (%) = 211 (74.3%) |
Crinone group N (%) = 72 (25.7%) |
p-value |
|---|---|---|---|---|
| Medication | Estradiol: N (Mean) | 205 (97.2) | 72 (98.6) | 0.682 |
| Other: N (Mean) | 6 (2.8) | 1 (1.4) | ||
| Endometrial preparation medication duration |
min–max | 9–21 | 9–21 | 0.114 |
| Mean ± SD | 14.9±2.0 | 15.3±2.2 | ||
| Median (P25–P75) | 15 (14–16) | 15 (14–17) | ||
| Embryo type | Cleavage stage embryo: N (Mean) |
139 (65.9) | 40 (54.8) | 0.091 |
| Blastocyst embryo: N (Mean) |
72 (34.1) | 33 (45.2) | ||
| Number of transferred embryos |
1: N (Mean) | 47 (22.3) | 17 (23.3) | 0.933 |
| 2: N (Mean) | 150 (71.1) | 52 (71.2) | ||
| 3: N (Mean) | 14 (6.6) | 4 (5.5) | ||
| Number of frozen embryos |
Min–max Mean ± SD Median (P25–P75) |
1 - 16 4±3 3 (2–6) |
1–12 3±3 2 (2–4) |
0.118 |
| Intervention duration | min–max | 2–8 | 2–7 | 0.587 |
| Mean ± SD | 4.6±1.1 | 4.7±1.2 | ||
| Median (P25 - P75) | 5 (4 - 6) | 5 (4 - 5) | ||